InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the full record of transactions filed by Sperzel John J III, 首席执行官. Officer active across 1 company, notably T2 Biosystems, Inc.. Cumulatively, 5 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €14k. History available since 7 April 2022. The latest transaction was disclosed on 7 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Sperzel John J III is Président, Directeur Général et Président at T2 Biosystems, Inc. He has 5 filings in total, and across the 5 most recent filings available, the transactions are dominated by option exercises, with total खरीद of EUR 13806 and no sales, over the period from 2022-02-28 to 2024-02-27.